SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-002211
Filing Date
2018-02-22
Accepted
2018-02-22 16:02:15
Documents
7
Period of Report
2018-02-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k022218a_biondvaxphrama.htm 6-K 21539
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL AND EXTRAORDINAR f6k022218aex99-1_biondvax.htm EX-99.1 264851
3 PROXY CARD f6k022218aex99-2_biondvax.htm EX-99.2 1127
4 GRAPHIC ex99-1_001.jpg GRAPHIC 8425
5 GRAPHIC ex99-1_002.jpg GRAPHIC 9931
6 GRAPHIC image_001.jpg GRAPHIC 146324
7 GRAPHIC image_002.jpg GRAPHIC 140338
  Complete submission text file 0001213900-18-002211.txt   709065
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 18632482
SIC: 2836 Biological Products, (No Diagnostic Substances)